Digital Pathology – An Advanced Way to Preserve Your Research Outcome In today’s rapidly evolving world of medical and scientific research, digital pathology has emerged as a cutting-edge solution that revolutionises the way pathologists and researchers approach diagnostics and data…
MYmAb Biologics Receives RM 1.3 Million GVPD Grant for Tissue Microarray Development August 2024: We are excited to announce that MYmAb Biologics Sdn. Bhd. has been awarded a generous RM 1.3 million under the prestigious Grant for High Value-Added Product…
Immunohistochemical Staining Breast Cancer: An Overview Breast cancer, a prevalent concern among women worldwide, requires precise diagnostic methods to tailor effective treatment plans. Immunohistochemical (IHC) staining has emerged as a crucial tool in this endeavor, offering insights into the biological…
What is Tissue Microarray? Tissue microarray (TMA) is a groundbreaking innovation in the field of pathology, designed to revolutionize how we analyze multiple tissue samples simultaneously. Imagine being able to study a hundred of different tissue samples on a single…